H. Yesid Estupiñán

Statistics

Publications

Citations

250

H-Index

Active since

2017

Affiliations

Industrial University of Santander(Current)

Karolinska Institutet

Karolinska University Hospital

Nanjing Medical University

Huaian First People’s Hospital

H. Yesid Estupiñán is an author at Industrial University of Santander specializing in btk inhibitors, bruton's tyrosine kinase inhibitors, and medicine.

ORCID

Publications per year

2017–2025

Publications

BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib

H. Yesid Estupiñán, Qing Wang, Anna Berglöf et al. · Leukemia · 2021 · 73 citations · Full text

Medicine, Oncology, Pharmacology +14

Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors

Xiuming Liang, Dhanu Gupta, Junhua Xie et al. · Nature Communications · 2025 · 73 citations · Full text

Pharmacy, Bioengineering, Biomedical Engineering +17

Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia

Tom A. Mulder, Lucía Peña‐Pérez, Anna Berglöf et al. · HemaSphere · 2021 · 23 citations · Full text

Medicine, Hematology, Pharmacology +17

Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors

Emilie Wahren Borgström, Marie Edvinsson, Lucía Peña‐Pérez et al. · Journal of Clinical Immunology · 2022 · 23 citations · Full text

Medicine, Dermatology, Immunology +17

Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects

H. Yesid Estupiñán, Thibault Bouderlique, Chenfei He et al. · Blood Advances · 2020 · 22 citations · Full text

Medicine, Immunology, Pharmacology +13

1–5 of 8